Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route
- 1 May 2001
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 37 (5) , 964-969
- https://doi.org/10.1016/s0272-6386(05)80012-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filterKidney International, 1998
- It is the goal of this section to publish material that provides information regarding specific issues, aspects of artificial organ application, approach, philosophy, suggestions, and/or thoughts for the future. 5‐Lipoxygenase Gene Expression in HemodialysisArtificial Organs, 1998
- Involvement of 5-lipoxygenase in programmed cell death of cancer cellsCell Death & Differentiation, 1997
- Membrane Modifications in Human Erythroleukemia K562 Cells During Induction of Programmed Cell Death by Transforming Growth Factor β1 or CisplatinEuropean Journal of Biochemistry, 1996
- Disruption of 12/15-Lipoxygenase Expression in Peritoneal MacrophagesJournal of Biological Chemistry, 1996
- Studies on the Regulation and Localization of 5‐Lipoxygenase in Human B‐LymphocytesEuropean Journal of Biochemistry, 1995
- Leukotriene B4 is involved in hemodialysis-associated neutropeniaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Vitamin E Therapy in Homozygous β-ThalassemiaNew England Journal of Medicine, 1981
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976